Why is Bliss GVS Pharma falling/rising?

As of 01-Jul, Bliss GVS Pharma Ltd's stock price is currently at 154.35, reflecting a decrease of 4.25, or 2.68%. The stock has underperformed its sector today by 2.47% and has experienced a trend reversal after two consecutive days of gains, touching an intraday low of Rs 153.8. Despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, the stock's delivery volume has fallen significantly, indicating reduced investor participation. Over the past year, while the stock has generated a return of 50.22%, it has also faced challenges, including a 19.5% decline in profits and negative results for the last three consecutive quarters, which may contribute to the current downward pressure on its price.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has risen by 2.00% over the past week. Although Bliss GVS Pharma has shown strong long-term performance, outperforming the BSE500 over the last three years, the recent decline in operating profit and the lack of domestic mutual fund investment may signal concerns about the company's growth prospects. This combination of factors, including a low debt-to-equity ratio and a fair valuation, suggests that while the stock has historically performed well, current negative trends and investor sentiment are influencing its recent price movement.